| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/NP50055A001 |
| P698 | PubMed publication ID | 3373220 |
| P2093 | author name string | R Sakai | |
| K L Rinehart | |||
| K C Bible | |||
| V Kishore | |||
| K M Li | |||
| D W Sullins | |||
| P433 | issue | 1 | |
| P921 | main subject | didemnin b | Q27137213 |
| didemnin a | Q27260029 | ||
| DQVGVYRSVYCJRR-AXRVZGOCSA-N | Q104252257 | ||
| FDHFJXKRMIVNCQ-CQBRDPJOSA-N | Q104252335 | ||
| Pheophorbide a | Q104253072 | ||
| 10-Hydroxyphaeophorbide | Q104392394 | ||
| N-[13-butan-2-yl-12-hydroxy-20-[(4-methoxyphenyl)methyl]-6,17,21-trimethyl-3-(2-methylpropyl)-2,5,7,10,15,19,22-heptaoxo-8-propyl-9,18-dioxa-1,4,14,21-tetrazabicyclo[21.3.0]hexacosan-16-yl]-2-[2-hydroxypropanoyl(methyl)amino]-4-methylpentanamide | Q105104071 | ||
| 3-[11-ethyl-16-(hydroxymethyl)-12,17,21,26-tetramethyl-4-oxo-7,23,24,25-tetraazahexacyclo[18.2.1.1⁵,⁸.1¹⁰,¹³.1¹⁵,¹⁸.0²,⁶]hexacosa-1(23),2(6),5(26),8,10,12,14,16,18(24),19-decaen-22-yl]propanoic acid | Q105286668 | ||
| Pheophytin a | Q110184831 | ||
| 3-[11-ethyl-4-hydroxy-16-(hydroxymethyl)-12,17,21,26-tetramethyl-7,23,24,25-tetraazahexacyclo[18.2.1.1⁵,⁸.1¹⁰,¹³.1¹⁵,¹⁸.0²,⁶]hexacosa-1(23),2(6),4,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid | Q110186337 | ||
| marine natural product | Q110316108 | ||
| zeaxanthin | Q169337 | ||
| natural product | Q901227 | ||
| Trididemnum solidum | Q4914602 | ||
| P304 | page(s) | 1-21 | |
| P577 | publication date | 1988-01-01 | |
| P1433 | published in | Journal of Natural Products | Q165584 |
| P1476 | title | Didemnins and tunichlorin: novel natural products from the marine tunicate Trididemnum solidum | |
| P478 | volume | 51 |
| Q72805217 | A phase II trial of didemnin B in myeloma. A Cancer and Leukemia Group B (CALGB) study |
| Q35156222 | Anti-inflammatory, Analgesic and Antiulcer properties of Porphyra vietnamensis |
| Q37369823 | Chlorinated didemnins from the tunicate Trididemnum solidum |
| Q105273336 | Corallistin A, a second example of a free porphyrin from a living organism. Isolation from the demospongeCorallistes sp. of the coral see and inhibition of abnormal cells |
| Q36329726 | Cyanobactins from Cyanobacteria: Current Genetic and Chemical State of Knowledge |
| Q40850718 | Drug discovery: past, present and future. |
| Q93590796 | Drugs and Cosmetics from the Sea |
| Q53374152 | Fishing for drugs from the sea: status and strategies. |
| Q96166469 | Highlights of marine natural products having parallel scaffolds found from marine-derived bacteria, sponges, and tunicates |
| Q42120421 | Hoiamide a, a sodium channel activator of unusual architecture from a consortium of two papua new Guinea cyanobacteria |
| Q43144569 | Isolation, structure elucidation, and synthesis of eudistomides A and B, lipopeptides from a Fijian ascidian Eudistoma sp. |
| Q92810162 | Marine Natural Products from the Yucatan Peninsula |
| Q53094795 | Marine natural product peptides with therapeutic potential: Chemistry, biosynthesis, and pharmacology. |
| Q44711294 | Molecular conformation of ascidiacyclamide, a cytotoxic cyclic peptide fromAscidian: X-ray analyses of its free form and solvate crystals |
| Q104912381 | On the Novel Free Porphyrins Corallistin B, C, D, and E: Isolation from the demospongeCorallistes sp. of the Coral Sea and Reactivity of Their Nickel 55 (II) Complexes toward Formylating Reagents |
| Q91643290 | Origins and Bioactivities of Natural Compounds Derived from Marine Ascidians and Their Symbionts |
| Q105219486 | Pictamine, a quinolizidine alkaloid from the tunicate clavelina picta |
| Q26796360 | Role of Marine Natural Products in the Genesis of Antiviral Agents |
| Q34501521 | Vanadium biochemistry: the unknown role of vanadium-containing cells in ascidians (sea squirts). |
Search more.